Missed GME or NVDA? Don’t Miss the Next One.
Join 5,000+ investors using Ticker Nerd’s Market Radar to stay ahead of major market moves, analyst upgrades, and trending opportunities — for free.
NGVT Stock Forecast 2025-2026
$40.46
Current Price
$1.48B
Market Cap
Buy 3
Hold 1
Sell 0
Wall St Analyst Ratings
Distance to NGVT Price Targets
+63.1%
To High Target of $66.00
+27.3%
To Median Target of $51.50
-6.1%
To Low Target of $38.00
NGVT Price Momentum
+13.9%
1 Week Change
+26.6%
1 Month Change
-25.7%
1 Year Change
-0.7%
Year-to-Date Change
-28.1%
From 52W High of $56.28
+42.0%
From 52W Low of $28.49
📉 MARKET SELLOFF ALERT
10 Quality Stocks Worth Considering Now
Researching Ingevity (NGVT) after the drop? Our ex-Goldman Sachs analyst reveals if it made our list of 10 oversold quality stocks with strong growth potential.
Get our FREE market selloff report + exclusive analysis on NGVT and similar high-potential opportunities.
Latest NGVT Stock Price Targets & Analyst Predictions
Based on our analysis of 10 Wall Street analysts, NGVT has a bullish consensus with a median price target of $51.50 (ranging from $38.00 to $66.00). The overall analyst rating is Strong Buy (8.0/10). Currently trading at $40.46, the median forecast implies a 27.3% upside. This outlook is supported by 3 Buy, 1 Hold, and 0 Sell ratings.
The most optimistic forecast comes from Michael Sison at Wells Fargo, projecting a 63.1% upside. Conversely, the most conservative target is provided by Michael Sison at Wells Fargo, suggesting a 6.1% downside.
Please note that analyst price targets are forward-looking estimates subject to substantial market, economic, and company-specific risks. Past performance does not guarantee future results, and actual stock performance may materially differ from these projections. Investors should conduct their own due diligence and consider their investment objectives and risk tolerance before making investment decisions.
NGVT Analyst Ratings
3
Buy
1
Hold
0
Sell
NGVT Price Target Range
Low
$38.00
Average
$51.50
High
$66.00
Current: $40.46
Latest NGVT Stock Forecasts by Analyst
These are the latest 20 analyst ratings and price targets for NGVT.
| Date | Firm | Analyst | Rating | Change | Price Target |
|---|---|---|---|---|---|
| May 7, 2025 | Wells Fargo | Michael Sison | Equal-Weight | Maintains | $38.00 |
| Apr 9, 2025 | Wells Fargo | Michael Sison | Equal-Weight | Maintains | $32.00 |
| Feb 26, 2025 | BMO Capital | John McNulty | Outperform | Upgrade | $65.00 |
| Feb 20, 2025 | BMO Capital | John McNulty | Market Perform | Maintains | $62.00 |
| Oct 31, 2024 | BMO Capital | John McNulty | Market Perform | Maintains | $47.00 |
| Sep 30, 2024 | BMO Capital | John McNulty | Market Perform | Maintains | $40.00 |
| Aug 5, 2024 | BMO Capital | John McNulty | Market Perform | Maintains | $42.00 |
| Aug 5, 2024 | Wells Fargo | Michael Sison | Equal-Weight | Maintains | $40.00 |
| Aug 1, 2024 | Oppenheimer | Ian Zaffino | Outperform | Maintains | $50.00 |
| Jul 11, 2024 | Wells Fargo | Michael Sison | Equal-Weight | Maintains | $45.00 |
| May 8, 2024 | BMO Capital | John McNulty | Market Perform | Maintains | $55.00 |
| May 7, 2024 | Loop Capital | Christopher Kapsch | Hold | Maintains | $56.00 |
| May 2, 2024 | Oppenheimer | Ian Zaffino | Outperform | Maintains | $58.00 |
| Apr 22, 2024 | Jefferies | Daniel Rizzo | Buy | Upgrade | $62.00 |
| Feb 23, 2024 | Wells Fargo | Michael Sison | Equal-Weight | Maintains | $50.00 |
| Nov 9, 2023 | BMO Capital | John McNulty | Market Perform | Maintains | $43.00 |
| Oct 3, 2023 | Loop Capital | Christopher Kapsch | Hold | Downgrade | $53.00 |
| Aug 7, 2023 | BMO Capital | John McNulty | Market Perform | Downgrade | $60.00 |
| Jul 27, 2023 | Loop Capital | Buy | Upgrade | $0.00 | |
| May 23, 2023 | Wells Fargo | Michael Sison | Equal-Weight | Maintains | $55.00 |
Ingevity Corporation (NGVT) Competitors
The following stocks are similar to Ingevity based on their market capitalization and industry sector. These similar stocks potentially provide investors with alternative investment opportunities within the same market segment.
Ingevity Corporation (NGVT) Financial Data
Ingevity Corporation has a market capitalization of $1.48B with a P/E ratio of 13.0x. The company generates $1.35B in trailing twelve-month revenue with a -26.2% profit margin.
Revenue growth is -16.5% quarter-over-quarter, while maintaining an operating margin of +22.0% and return on equity of -88.1%.
Valuation Metrics
Market Cap
$1.48B
Enterprise Value
$2.75B
P/E Ratio
13.0x
PEG Ratio
10.0x
Price/Sales
1.1x
Growth & Margins
Revenue Growth (YoY)
-16.5%
Gross Margin
+39.9%
Operating Margin
+22.0%
Net Margin
-26.2%
EPS Growth
-16.5%
Financial Health
Cash/Price Ratio
+4.9%
Current Ratio
2.0x
Debt/Equity
593.8x
ROE
-88.1%
ROA
+7.7%
💰 DON'T MISS THIS OPPORTUNITY
Get All 10 Quality Stocks For This Market Selloff
Still researching investments after the market drop? Our ex-Goldman Sachs analyst has already identified the 10 highest-quality oversold stocks with strong fundamentals and upside potential.
Why spend hours researching when we've already done the work? Get instant access to our complete market selloff analysis.
Ingevity Corporation (NGVT) Business Model
About Ingevity Corporation
What They Do
Manufactures specialty chemicals and carbon materials.
Business Model
Ingevity Corporation generates revenue by producing specialty chemicals and high-performance carbon materials that cater to various industries, particularly automotive, construction, and industrial applications. Their activated carbon products help reduce vehicle emissions, while their chemical solutions are essential in manufacturing adhesives, lubricants, and pavement technologies.
Additional Information
With a long history of expertise, Ingevity emphasizes sustainability in its product offerings and manufacturing processes. The company plays a significant role in the specialty chemicals market, contributing to environmental compliance and efficiency across multiple sectors.
Company Information
Sector
Basic Materials
Industry
Specialty Chemicals
Employees
1,600
CEO
Mr. David H. Li
Country
United States
IPO Year
2016
Website
www.ingevity.comIngevity Corporation (NGVT) Latest News & Analysis
Featured Analysis
Powered by
Zacks Investment Research
Ingevity Q1 Earnings Up, Revenues Down Y/Y on Repositioning Actions
NGVT's earnings increase, but revenues are impacted by the Performance Chemical segment's repositioning measures.
May 09, 2025
By Zacks Equity Research
Analyst Blog
Latest News
Quick Summary
NGVT reports increased earnings; however, revenues are affected due to repositioning measures in the Performance Chemical segment.
Why It Matters
NGVT's earnings growth indicates operational efficiency, but revenue challenges in the Performance Chemical segment may signal potential volatility and future performance concerns.
Source: Zacks Investment Research
Market Sentiment:
Neutral
Quick Summary
Ingevity Corporation (NYSE: NGVT) will hold its Q1 2025 earnings call on May 6, 2025, at 9:00 AM ET, featuring key executives and analysts from various financial institutions.
Why It Matters
Ingevity's Q1 2025 earnings call will provide insights into its financial performance and strategic direction, influencing investor sentiment and stock valuation.
Source: Seeking Alpha
Market Sentiment:
Neutral
Quick Summary
Ingevity Corporation (NYSE: NGVT) has released its financial results for Q1 2025. Further details on performance and metrics are available in the full report.
Why It Matters
Ingevity's Q1 2025 financial results can influence stock performance, revealing growth trends, profitability, and operational efficiency, directly impacting investor sentiment and decisions.
Source: Business Wire
Market Sentiment:
Neutral
Quick Summary
Ingevity has scheduled its first-quarter 2025 earnings release and webcast dates.
Why It Matters
Earnings release dates signal upcoming financial performance insights, impacting stock valuations and investor sentiment toward Ingevity.
Source: Business Wire
Market Sentiment:
Neutral
Quick Summary
NGVT is experiencing growth due to the repositioning of its Performance Chemicals segment and strategic acquisitions.
Why It Matters
NGVT's repositioning and strategic acquisitions indicate potential revenue growth and improved market positioning, signaling a positive outlook for future performance and shareholder value.
Source: Zacks Investment Research
Market Sentiment:
Positive
Quick Summary
NGVT's stock rises due to the repositioning of its Performance Chemicals segment and strategic acquisitions aimed at driving growth.
Why It Matters
NGVT's repositioning and strategic acquisitions signal potential for revenue growth and improved market positioning, which can enhance shareholder value and attract investment interest.
Source: Zacks Investment Research
Market Sentiment:
Positive
Frequently Asked Questions About NGVT Stock
What is Ingevity Corporation's (NGVT) stock forecast for 2025?
Based on our analysis of 10 Wall Street analysts, Ingevity Corporation (NGVT) has a median price target of $51.50. The highest price target is $66.00 and the lowest is $38.00.
Is NGVT stock a good investment in 2025?
According to current analyst ratings, NGVT has 3 Buy ratings, 1 Hold ratings, and 0 Sell ratings. The stock is currently trading at $40.46. Always conduct your own research and consider your investment goals before making investment decisions.
What is the long-term price prediction for NGVT stock?
Wall Street analysts predict NGVT stock could reach $51.50 in the next 12 months. This represents a 27.3% increase from the current price of $40.46. Please note that this is a projection by Wall Street analysts and not a guarantee.
What is Ingevity Corporation's business model?
Ingevity Corporation generates revenue by producing specialty chemicals and high-performance carbon materials that cater to various industries, particularly automotive, construction, and industrial applications. Their activated carbon products help reduce vehicle emissions, while their chemical solutions are essential in manufacturing adhesives, lubricants, and pavement technologies.
What is the highest forecasted price for NGVT Ingevity Corporation?
The highest price target for NGVT is $66.00 from Michael Sison at Wells Fargo, which represents a 63.1% increase from the current price of $40.46.
What is the lowest forecasted price for NGVT Ingevity Corporation?
The lowest price target for NGVT is $38.00 from Michael Sison at Wells Fargo, which represents a -6.1% decrease from the current price of $40.46.
What is the overall NGVT consensus from analysts for Ingevity Corporation?
The overall analyst consensus for NGVT is bullish. Out of 10 Wall Street analysts, 3 rate it as Buy, 1 as Hold, and 0 as Sell, with a median price target of $51.50.
How accurate are NGVT stock price projections?
Stock price projections, including those for Ingevity Corporation, are based on various factors including financial models, market conditions, and analyst forecasts. While these predictions provide valuable insights, they should be considered alongside your own research and risk tolerance.
Important Disclaimer
The information provided by Ticker Nerd is for educational and informational purposes only. It should not be considered financial or investment advice. Past performance is not indicative of future results. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions. Analyst ratings and price forecasts are sourced from Wall St analysts and other experts. These projections are speculative and do not guarantee future stock performance.
Last updated: May 11, 2025 4:00 PM UTC